Liquidity ratios measure the company ability to meet its short-term obligations.
Paying user area
Try for free
Medtronic PLC pages available for free this week:
- Balance Sheet: Assets
- Common-Size Balance Sheet: Assets
- Analysis of Geographic Areas
- Enterprise Value (EV)
- Enterprise Value to FCFF (EV/FCFF)
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Net Profit Margin since 2005
- Return on Equity (ROE) since 2005
- Price to Earnings (P/E) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Medtronic PLC for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Liquidity Ratios (Summary)
| Apr 24, 2026 | Apr 25, 2025 | Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | ||
|---|---|---|---|---|---|---|---|
| Current ratio | |||||||
| Quick ratio | |||||||
| Cash ratio |
Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).
An evaluation of liquidity ratios from 2021 to 2026 reveals a general contraction in short-term liquidity buffers following a peak in 2021, although the organization maintains a position sufficient to cover current liabilities across the entire observed period.
- Current Ratio
- The current ratio exhibits volatility, beginning at a high of 2.65 in 2021 before declining to 1.86 in 2022. A subsequent recovery to 2.39 was observed in 2023, followed by a gradual decline to a period low of 1.85 in 2025. By 2026, the ratio improved to 2.13, suggesting a consistent ability to meet short-term obligations with current assets, maintaining a margin well above the 1.0 threshold.
- Quick Ratio
- The quick ratio follows a trajectory similar to the current ratio, starting at 1.91 in 2021 and dropping to 1.30 in 2022. After a moderate increase to 1.54 in 2023, the ratio trended downward to 1.20 by 2025 before recovering to 1.36 in 2026. The consistent gap between the current and quick ratios indicates that a portion of the liquidity is tied up in inventory, yet the company remains capable of meeting immediate liabilities without relying on inventory liquidation.
- Cash Ratio
- The cash ratio shows the most significant relative decline, falling from 1.27 in 2021 to 0.85 in 2022. Unlike the other liquidity metrics, the cash ratio remained below 1.0 for the remainder of the period, reaching a low of 0.70 in 2025 before a slight increase to 0.79 in 2026. This trend suggests a strategic shift or a reduction in the proportion of highly liquid cash and cash equivalents held relative to total current liabilities.
Overall, the data indicates a transition from a highly liquid posture in 2021 to a more lean liquidity management approach. While all three ratios experienced a downward trend through 2025, the recovery observed in 2026 suggests a stabilization of short-term financial health.
Current Ratio
| Apr 24, 2026 | Apr 25, 2025 | Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||
| Current assets | |||||||
| Current liabilities | |||||||
| Liquidity Ratio | |||||||
| Current ratio1 | |||||||
| Benchmarks | |||||||
| Current Ratio, Competitors2 | |||||||
| Abbott Laboratories | |||||||
| Elevance Health Inc. | |||||||
| Intuitive Surgical Inc. | |||||||
| UnitedHealth Group Inc. | |||||||
| Current Ratio, Sector | |||||||
| Health Care Equipment & Services | |||||||
| Current Ratio, Industry | |||||||
| Health Care | |||||||
Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).
1 2026 Calculation
Current ratio = Current assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
The liquidity position of the organization remains strong throughout the period from 2021 to 2026, characterized by a current ratio that consistently stays well above 1.0. This indicates a sustained ability to cover short-term obligations using short-term assets, providing a significant margin of safety against liquidity risks.
- Current Asset Trends
- Current assets exhibit a general upward trajectory over the six-year period. Starting at US$ 22,548 million in 2021, assets reached a peak of US$ 24,787 million by 2026. Although a temporary contraction occurred in 2023, the subsequent growth indicates an expansion of the company's liquid resource base.
- Current Liability Trends
- Current liabilities demonstrate significant volatility. A sharp increase was observed in 2022, rising to US$ 12,394 million from US$ 8,509 million in the prior year. This was followed by a reduction in 2023, another increase peaking in 2025 at US$ 12,879 million, and a subsequent decline in 2026. This pattern suggests fluctuating short-term financing needs or changes in working capital management.
- Current Ratio Analysis
- The current ratio reflects the volatility seen in the liabilities, oscillating between a high of 2.65 in 2021 and a low of 1.85 in 2025. The declines observed in 2022 and 2025 correlate directly with the spikes in current liabilities. Despite these fluctuations, the ratio remains healthy, closing the period at 2.13 in 2026, which suggests that the organization maintains a conservative liquidity profile.
Quick Ratio
| Apr 24, 2026 | Apr 25, 2025 | Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||
| Cash and cash equivalents | |||||||
| Investments | |||||||
| Accounts receivable, less allowances and credit losses | |||||||
| Total quick assets | |||||||
| Current liabilities | |||||||
| Liquidity Ratio | |||||||
| Quick ratio1 | |||||||
| Benchmarks | |||||||
| Quick Ratio, Competitors2 | |||||||
| Abbott Laboratories | |||||||
| Elevance Health Inc. | |||||||
| Intuitive Surgical Inc. | |||||||
| UnitedHealth Group Inc. | |||||||
| Quick Ratio, Sector | |||||||
| Health Care Equipment & Services | |||||||
| Quick Ratio, Industry | |||||||
| Health Care | |||||||
Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).
1 2026 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
The analysis of liquidity indicators reveals a general decline in the immediate coverage capacity over the observed six-year period, despite the maintenance of a ratio above 1.0. While the organization consistently retains sufficient quick assets to cover its current liabilities, the margin of safety has contracted from its peak in 2021.
- Total Quick Assets Trend
- Quick assets experienced a period of decline starting from 16,279 million US$ in 2021, reaching a minimum of 13,957 million US$ in 2023. Following this trough, a steady recovery phase is observed, with assets increasing to 15,863 million US$ by 2026, nearly returning to the initial 2021 levels.
- Current Liabilities Volatility
- Current liabilities exhibit significant volatility throughout the period. A sharp increase occurred between 2021 and 2022, rising from 8,509 million US$ to 12,394 million US$. After a temporary reduction in 2023, liabilities trended upward again to a peak of 12,879 million US$ in 2025, before declining to 11,658 million US$ in 2026.
- Quick Ratio Performance
- The quick ratio shows a downward trajectory, falling from a high of 1.91 in 2021 to a low of 1.20 in 2025. Although a moderate recovery to 1.36 is noted in 2026, the ratio remains substantially lower than the 2021 baseline. The fluctuations in the ratio are primarily driven by the instability in current liabilities rather than the movements in quick assets.
In summary, the liquidity position remains stable in absolute terms, as the quick ratio has not fallen below the critical threshold of 1.0. However, the compression of this ratio suggests a heightened reliance on asset management and a reduction in the available liquidity buffer to meet short-term obligations.
Cash Ratio
| Apr 24, 2026 | Apr 25, 2025 | Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||
| Cash and cash equivalents | |||||||
| Investments | |||||||
| Total cash assets | |||||||
| Current liabilities | |||||||
| Liquidity Ratio | |||||||
| Cash ratio1 | |||||||
| Benchmarks | |||||||
| Cash Ratio, Competitors2 | |||||||
| Abbott Laboratories | |||||||
| Elevance Health Inc. | |||||||
| Intuitive Surgical Inc. | |||||||
| UnitedHealth Group Inc. | |||||||
| Cash Ratio, Sector | |||||||
| Health Care Equipment & Services | |||||||
| Cash Ratio, Industry | |||||||
| Health Care | |||||||
Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).
1 2026 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
The liquidity position of the entity demonstrates a general downward trend in cash coverage over the observed six-year period. While the company maintained a highly liquid position in 2021, characterized by the ability to cover all current liabilities using only cash assets, subsequent years show a transition toward a more constrained liquidity profile with a gradual attempt at stabilization in the final year.
- Cash Ratio Trend
- A significant contraction in the cash ratio is observed, falling from 1.27 in April 2021 to a low of 0.70 by April 2025. This represents a shift from a surplus liquidity position to one where cash assets cover only 70% of short-term obligations. A slight recovery to 0.79 occurred in April 2026, suggesting a marginal improvement in immediate liquidity.
- Total Cash Asset Movements
- Cash holdings experienced a period of decline between 2021 and 2023, dropping from 10,817 million US$ to 7,959 million US$. Following this trough, a consistent upward trajectory was established from 2024 through 2026, with assets reaching 9,220 million US$. Despite this recovery, cash levels remain below the 2021 peak.
- Current Liabilities Dynamics
- Short-term obligations exhibited considerable volatility. Liabilities increased sharply from 8,509 million US$ in 2021 to 12,394 million US$ in 2022, followed by a temporary decrease in 2023. A second peak occurred in April 2025 at 12,879 million US$, before receding to 11,658 million US$ in April 2026. The overall increase in the baseline of current liabilities has contributed to the systemic compression of the cash ratio.
- Liquidity Correlation
- The decline in the cash ratio was driven by a dual impact: the reduction of cash reserves during the first half of the period and the simultaneous expansion of current liabilities. The improvement in the ratio observed in 2026 is attributable to the combined effect of rising cash assets and a reduction in current liabilities.